These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6381872)

  • 1. Immunohistological skin alterations in allogeneic bone marrow transplantation.
    Müller C; Ostendorf P; Wernet P; Schüch K; Wahl H; Waller HD
    Klin Wochenschr; 1984 Jul; 62(14):675-88. PubMed ID: 6381872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistology of graft-versus-host disease mediated skin lesions and its correlation to a large granular lymphocyte surface phenotype and function.
    Müller C; Schüch K; Pawelec G; Wilms K; Wernet P
    Blut; 1982 Feb; 44(2):89-94. PubMed ID: 7037077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
    Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
    J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
    Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
    Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Langerhans cells after allogeneic bone marrow transplantation.
    Perreault C; Pelletier M; Landry D; Gyger M
    Blood; 1984 Apr; 63(4):807-11. PubMed ID: 6367851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.
    Sviland L; Pearson AD; Green MA; Baker BD; Eastham EJ; Reid MM; Hamilton PJ; Proctor SJ; Malcolm AJ
    Transplantation; 1991 Dec; 52(6):1029-36. PubMed ID: 1836284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
    Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
    J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of human cytomegalovirus on immune reconstitution after bone marrow transplantation.
    Müller CA; Einsele H
    Ann Hematol; 1992 Jun; 64 Suppl():A140-2. PubMed ID: 1322185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous leucocyte composition after human allogeneic bone marrow transplantation: relationship to marrow purging, histology and clinical rash.
    Elliott CJ; Sloane JP; Pallett CD; Sanderson KV
    Histopathology; 1988 Jan; 12(1):1-16. PubMed ID: 3286467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
    Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimerism in skin of bone marrow transplant recipients.
    Thomas JA; Wakeling WF; Imrie SF; Sloane JP; Powles RL; Lawler SD
    Transplantation; 1984 Nov; 38(5):475-8. PubMed ID: 6208658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological analysis of the skin in graft versus host disease.
    Lampert IA; Janossy G; Suitters AJ; Bofill M; Palmer S; Gordon-Smith E; Prentice HG; Thomas JA
    Clin Exp Immunol; 1982 Oct; 50(1):123-31. PubMed ID: 6756725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center].
    van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM
    Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.